You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 9,649,280

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,649,280 protect, and when does it expire?

Patent 9,649,280 protects ALKINDI SPRINKLE and is included in one NDA.

This patent has thirty patent family members in twenty-five countries.

Summary for Patent: 9,649,280

Title:	Composition comprising hydrocortisone
Abstract:	The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.
Inventor(s):	Huatan; Hiep (Maidstone, GB), Ross; Richard (Sheffield, GB), Whitaker; Martin (Nottingham, GB), Poellinger; Norbert (Mullheim, DE), Grave; Annette (Lorrach, DE)
Assignee:	Diurnal Limited (Cardiff, GB)
Application Number:	14/888,648
Patent Claim Types: see list of patent claims	Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 9,649,280

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-001	Sep 29, 2020		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Try a Trial
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-002	Sep 29, 2020		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Try a Trial
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-003	Sep 29, 2020		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Try a Trial
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-004	Sep 29, 2020		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,649,280

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	1308933.9	May 17, 2013

PCT Information
PCT Filed	May 12, 2014	PCT Application Number:	PCT/GB2014/051442
PCT Publication Date:	November 20, 2014	PCT Publication Number:	WO2014/184525

International Family Members for US Patent 9,649,280

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014267041	⤷ Try a Trial
Brazil	112015028025	⤷ Try a Trial
Canada	2909060	⤷ Try a Trial
China	105120848	⤷ Try a Trial
Cyprus	1123284	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.